A new study by C. Shad Thaxton, M.D., and Leo I. Gordon, M.D. shows that synthetic HDL nanoparticles killed B-cell lymphoma, the most common form of the disease, in cultured human cells, and inhibited human B-cell lymphoma tumor growth in mice. The paper will be published in the journal Proceedings of the National Academy of Sciences. Read more here.
Study mentioned: Yang S, et al. Biomimetic, synthetic HDL nanostructures for lymphoma. Proc Natl Acad Sci U S A. 2013 Jan 23. [Epub ahead of print] PMID: 23345442
No comments:
Post a Comment